POST-SURGICAL TREATMENT of patients with differentiated thyroid cancer consists of ablation of residual thyroid tissue, followed by cyclic treatments with I-131 until a complete remission has been achieved.1 Usually the re
Abstract: Aim: Recombinant human thyroid-stimulating hormone (rhTSH) has been approved in Europe as ...
In this thesis several studies on the treatment and follow-up of differentiated thyroid carcinoma ar...
Radioactive iodine therapy is administered to patients with differentiated thyroid cancer (DTC) for ...
THE PRIMARY TREATMENT for differentiated thyroid cancer (DTC) consists of surgical thyroidectomy, su...
Post-surgical ablation of thyroid remnant with radioactive iodine (RAI) in differentiated thyroid ca...
Postoperative ablation of functioning thyroid tissue has become established in the management of dif...
For many years the recommended therapy for differentiated thyroid carcinoma (DTC), with the exceptio...
Due to the growing incidence of differentiated thyroid carcinoma (DTC) and in particular of small pa...
Thyroid cancer is the most common endocrine malignancy. More than 90% of primary thyroid cancers are...
Differentiated thyroid cancer is the most frequent type of thyroid cancer with an increasing inciden...
Radioactive iodine ablation therapy is a standard treatment for most patients with differentiated th...
Post-surgical ablation of thyroid remnant with radioactive iodine (RAI) in differentiated thyroid ca...
Differentiated thyroid cancer (DTC) is the most common endocrine malignancy with the highest mortali...
Contains fulltext : 153820.PDF (publisher's version ) (Open Access)INTRODUCTION: P...
Total thyroidectomy is the primary treatment of thyroid cancer. Therapy with radioiodine (131I) afte...
Abstract: Aim: Recombinant human thyroid-stimulating hormone (rhTSH) has been approved in Europe as ...
In this thesis several studies on the treatment and follow-up of differentiated thyroid carcinoma ar...
Radioactive iodine therapy is administered to patients with differentiated thyroid cancer (DTC) for ...
THE PRIMARY TREATMENT for differentiated thyroid cancer (DTC) consists of surgical thyroidectomy, su...
Post-surgical ablation of thyroid remnant with radioactive iodine (RAI) in differentiated thyroid ca...
Postoperative ablation of functioning thyroid tissue has become established in the management of dif...
For many years the recommended therapy for differentiated thyroid carcinoma (DTC), with the exceptio...
Due to the growing incidence of differentiated thyroid carcinoma (DTC) and in particular of small pa...
Thyroid cancer is the most common endocrine malignancy. More than 90% of primary thyroid cancers are...
Differentiated thyroid cancer is the most frequent type of thyroid cancer with an increasing inciden...
Radioactive iodine ablation therapy is a standard treatment for most patients with differentiated th...
Post-surgical ablation of thyroid remnant with radioactive iodine (RAI) in differentiated thyroid ca...
Differentiated thyroid cancer (DTC) is the most common endocrine malignancy with the highest mortali...
Contains fulltext : 153820.PDF (publisher's version ) (Open Access)INTRODUCTION: P...
Total thyroidectomy is the primary treatment of thyroid cancer. Therapy with radioiodine (131I) afte...
Abstract: Aim: Recombinant human thyroid-stimulating hormone (rhTSH) has been approved in Europe as ...
In this thesis several studies on the treatment and follow-up of differentiated thyroid carcinoma ar...
Radioactive iodine therapy is administered to patients with differentiated thyroid cancer (DTC) for ...